Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Bezafibrate1件: Bezafibrate1件: D01366 1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬7件: 20, 93, 94, 160, 296, 316, 324
2Bezafibrate (drug)1件: Bezafibrate1件: D01366 1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 316
3Break in L-carnitine treatment1件: Levocarnitine3件: D02030 ,
D02176 ,
D04713 		--1件: 316
4Carnitine1件: Levocarnitine3件: D02030 ,
D02176 ,
D04713 		--9件: 5, 13, 58, 86, 96, 97, 265, 298, 316
5Glycerol1件: Glycerin1件: D00028 --5件: 6, 13, 79, 316, 317
6Glycerol/Saline1件: Glycerin1件: D00028 --2件: 316, 317
7Heparin1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬12件: 47, 60, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317
8Hyperinsulinemic euglycemic clamp----2件: 316, 317
9Intralipid/Heparin1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬2件: 316, 317
10L-Carnitine1件: Levocarnitine3件: D02030 ,
D02176 ,
D04713 		--7件: 13, 86, 96, 97, 265, 298, 316